Trial Profile
A phase I study of AIT-082 in healthy elderly volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Leteprinim potassium (Primary)
- Indications Alzheimer's disease; Memory disorders
- Focus Pharmacokinetics
- 05 Nov 2010 New trial record.